Celiac Disease in Uzbek Children: Insights into Disease Prevalence and Clinical Characteristics in Symptomatic

Altinoy T Kamilova1, Gulnoza K Azizova1, Dimitri Poddighe2,3

  • 1Gastroenterology Department, Pediatric Republican Specialized Scientific-Practical Medical Center of the Ministry of Health of Republic of Uzbekistan, Tashkent 100179, Uzbekistan.

PubMed

Insights

This study found a 5.3% prevalence of pediatric Celiac Disease (CD) in Uzbekistan among symptomatic children. Many diagnosed children presented with typical symptoms like watery diarrhea, suggesting potential diagnostic delays.

Area of Science:

  • Pediatric Gastroenterology
  • Immunogenetics
  • Celiac Disease Research

Background:

  • Limited data exists on pediatric Celiac Disease (CD) in Central Asia.
  • Immunogenetic and dietary factors in Central Asia resemble regions with high CD prevalence.
  • This study addresses the knowledge gap in Uzbek pediatric CD.

Purpose of the Study:

  • To investigate the prevalence and clinical characteristics of Celiac Disease (CD) in symptomatic children in Uzbekistan.
  • To assess serological, histopathological, and immunogenetic markers in pediatric CD patients.
  • To evaluate fecal zonulin and pancreatic elastase levels in the study population.

Main Methods:

  • Prospective, cross-sectional study of 206 symptomatic children in Uzbekistan (Sept 2021-July 2022).
  • Clinical data, laboratory analyses, and guardian surveys were collected.
  • Assessed anti-tissue transglutaminase IgA (anti-tTG IgA), histopathology, fecal zonulin, and pancreatic elastases.

Main Results:

  • Celiac Disease (CD) was diagnosed in 11 children (5.3% prevalence).
  • Watery diarrhea was significantly more common in CD patients.
  • All CD patients had elevated anti-tTG IgA and Marsh III histology, indicating potential diagnostic delays.

Conclusions:

  • A significant prevalence of Celiac Disease (CD) is suggested in Uzbek children, based on symptomatic cases.
  • The high occurrence of typical CD forms with watery diarrhea warrants a comprehensive diagnostic approach.
  • Elevated anti-tTG IgA and Marsh grade suggest possible diagnostic delays in recognizing CD.
Abstract

Related Concept Videos

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
170
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
151
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
339
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.3K
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
307
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
196